Child with rare epileptic disorder receives long-awaited diagnosis
Researchers provided a long-awaited and rare genetic diagnosis in a child with Lennox-Gastaut syndrome, a type of ...
GBS Virus In India Reaches All Time Scare: Outbreak Updates, Symptoms & What To Watch Out For
India is facing a GBS (Guillain-Barré Syndrome) outbreak, especially in Maharashtra and Mumbai. Cases are rising, including ...
KOIN Portland on MSN2 小时
Portugal. The Man highlight rare disease month as bandmember’s daughter battles genetic ...
February is Rare Disease Month, an annual effort to highlight the challenges families can face while navigating rare ...
The Financial Express5 小时
GBS spreads in South India, These are the states affected
The Guillain-Barré Syndrome (GBS) is slowly spreading its tentacles to the south with Andhra Pradesh reporting its first ...
Gene 'silencer' in junk DNA prevents fatal neurological disease
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene ...
The Financial Express5 小时
Mumbai records first Guillain-Barré Syndrome death, total 8 in Maharashtra
With nearly 200 cases in Maharashtra, the 53-year-old patient was admitted to Nayar Hospital and was on a ventilator and ...
Ozzy Osbourne shares health update amid Parkingson's battle ahead of Black Sabbath show
The heavy metal singer has opened up about his health battles as tickets go on sale for the Back To The Beginning gig ...
‘Walking on eggshells’: Trump administration’s move to slash NIH grant support leaves ...
After the National Institutes of Health issued an order Friday night that would dramatically reduce funding, professor ...
ACD Awards $145,000 To Advance Creatine Deficiency Research At Six Research Centers
ACD Fellowship Awardees 2025 Young Investigator Awardee Researchers at six institutions funded by Association for Creatine Defi ...
Taiwan News13 小时
Ipsen delivers solid results in 2024, driven by strong performance across all therapeutic ...
Ipsen improved further the depth and breadth of its pipeline by adding five preclinical innovative therapies with global rights and new modalities, and an ex-U.S. licensing agreement with DayOne ...